Toxicity Associated with Stavudine Dose Reduction from 40 to 30 mg in First-Line Antiretroviral Therapy

BACKGROUND: To compare the incidence and timing of toxicity associated with the use of a reduced dose of stavudine from 40 to 30 mg in first-line antiretroviral therapy (ART) for HIV treatment and to investigate associated risk factors. METHODS: Multicohort study including 23 HIV programs in resourc...

Descripción completa

Detalles Bibliográficos
Autores principales: Pujades-Rodríguez, Mar, Dantony, Emmanuelle, Pinoges, Loretxu, Ecochard, René, Etard, Jean-François, Carrillo-Casas, Esther, Szumilin, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221698/
https://www.ncbi.nlm.nih.gov/pubmed/22132226
http://dx.doi.org/10.1371/journal.pone.0028112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221698/
https://www.ncbi.nlm.nih.gov/pubmed/22132226
http://dx.doi.org/10.1371/journal.pone.0028112

Ejemplares similares